New

NexCAR19 CAR-T Therapy

  • President Draupadi Murmu launched the country's first indigenous anti-cancer CAR-T cell therapy NexCAR19.
  • It has been prepared jointly by IIT Bombay and Tata Memorial Centre.
  • This therapy is a form of immunotherapy and gene therapy.
    • In this, T cells (immune cells) are made stronger.
    • These T-cells attack cancer cells.
  • This treatment will be comparatively very cheap in India.
    • The cost of this treatment abroad is approximately ₹ 4 crore.
    • This treatment will be possible in India for approximately ₹ 30 lakh.

More Articles

India's first green hydrogen pilot project
UN Trade and Development
Centralized Public Grievance Redressal and Monitoring System
International Disaster Resilient Infrastructure Conference
Mount Erebus Volcano
National Fertilizers Limited
Patient Safety Rights Charter
Navchetna Framework
Mount Ruang Volcano
India's 'Act East' policy
« »
  • SUN
  • MON
  • TUE
  • WED
  • THU
  • FRI
  • SAT
Have any Query?

Our support team will be happy to assist you!

call us

+91-9555 124 124
OR